Devyser Diagnostics AB (publ) (DVYSR.ST)

99.80 +0.80 (+0.81%) At close: 05:24PM CEST

Devyser Diagnostics AB (publ)

Instrumentvägen 19
Hägersten 126 53
Sweden
46 8 56 21 58 50
https://devyser.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 118

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Fredrik Alpsten	Chief Executive Officer	4.9M	N/A	1966
Ms. Sabina Berlin	Chief Financial Officer	N/A	N/A	1983
Mr. Goran Rydin	Chief Operating Officer	N/A	N/A	1969
Mr. Michael Uhlin Ph.D.	Chief Scientific Officer	N/A	N/A	1978
Ms. Camilla Wiberg	Chief Human Resource Officer	N/A	N/A	1979
Mr. Theis Kipling	Chief Commercial Officer	N/A	N/A	1982
Mr. John Murad	VP & GM of Devyser US	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation; thalassemia; breast, colorectal, and ovarian cancer; non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company also provides software programs for data processing and analysis, as well as interpretation of test results; and Amplicon Suite and Advyser software programs to screen markers and follow up samples for the same patient. Devyser Diagnostics AB (publ) was incorporated in 2004 and is headquartered in Hägersten, Sweden.

Corporate governance

Devyser Diagnostics AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.